NCT00258570 Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
| NCT ID | NCT00258570 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Pulmonary Fibrosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2003-01 |
| Primary Completion | 2035-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2003-01 with a primary completion date of 2035-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Diagnosis of pulmonary fibrosis confirmed by physical examination, pulmonary function testing, chest X-ray, and computed tomography (CT) scans. * Adult patients who are seeking treatment at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease. Exclusion Criteria: * Under 18 years of age * Non-fibrotic ILD
Contact & Investigator
Kevin F Gibson, MD
PRINCIPAL INVESTIGATOR
University of Pittsburgh, Simmons Center for ILD
Frequently Asked Questions
Who can join the NCT00258570 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Fibrosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00258570 currently recruiting?
Yes, NCT00258570 is actively recruiting participants. Contact the research team at macphersonmj@upmc.edu for enrollment information.
Where is the NCT00258570 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT00258570 clinical trial?
NCT00258570 is sponsored by University of Pittsburgh. The principal investigator is Kevin F Gibson, MD at University of Pittsburgh, Simmons Center for ILD. The trial plans to enroll 2,000 participants.